Covid-19: Immunology Research
Debate between Rupa Huq and Anum Qaisar(3 years, 3 months ago)
Westminster HallRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Dr Rupa Huq (in the Chair)
On the Clerk’s advice, let me gently remind the hon. Member that, as we are talking about the Westminster Parliament, she should not stray too much into what goes on in the devolved Parliaments.
Anum Qaisar-Javed
I do not know off the top of my head, so I will get back to the hon. Gentleman on that matter.
In light of the statistics and the current rates of covid-19, it is crucial that there is continued investment in immunology research, which will allow us to develop an ongoing public health strategy to minimise and manage the impact of the virus on our population. Thanks to the production of the vaccine, when compared to those who are unvaccinated, those who are double vaccinated are at less risk not only of catching the virus, but of an infection turning into long covid.
Furthermore, it has been found that two doses of the Pfizer or Oxford-AstraZeneca vaccine are 96% and 92% effective against hospitalisation with the delta variant, respectively. While the delta variant is prevalent throughout the country, it is reassuring to know that because of the work of immunologists, our population is trying to live life as normally as possible. The vaccine produced by immunologists has both literally and figuratively provided us with a lifeline—without their work, our economy would remain at a standstill.
Despite the steps we have taken in the battle against covid-19, there is still so much we do not fully understand. By continuing to fund immunology research, population-based studies—a key strength of UK research—can continue to provide us with this knowledge. For example, the National Institute for Health Research has played a major role in bringing academic research together with clinical services during the pandemic, ensuring that we learn as we go. It is this continual production of real-time information about covid-19 that will allow us to overcome and stay ahead of the virus and its long-term impacts.
I therefore ask that the UK Government follow the lead of the Scottish Government’s actions and continue to invest in immunology research and ensure the necessary investment in England’s NHS. It is through further investment in this research that we will get the pandemic under control. In turn, this will ensure that the country is far better prepared for any future outbreaks of emerging diseases. Immunology research has undoubtedly played a pivotal role in our overcoming the pandemic, and it will continue to form the foundation of our public health response and our knowledge of the ever-changing landscape of the pandemic.